S&P Global Ratings assigned its 'AA-' long-term rating to the North Carolina Medical Care Commission?s anticipated $170.75 million series 2026A revenue bonds, issued for CaroMont Health. At the same time, we assigned our 'AA+/A-1' dual rating and 'AA-' underlying rating (SPUR) to the commission?s anticipated $101.0 million series 2026B variable rate demand bonds (VRDBs), issued for CaroMont Health. At the same time, we affirmed our 'AA-' long-term rating on the commission?s series 2021A tax-exempt revenue bonds, issued for CaroMont Health. Lastly, we affirmed our 'AA-' issuer credit rating (ICR) on CaroMont Health. The outlook on the long-term ratings is stable. LANSING (S&P Global Ratings) Sep. 22, 2026—S&P Global Ratings today took the rating actions listed above. The stable outlook reflects
